The startup develops a biology platform utilizing integrated micro-electro-mechanical systems to enhance treatment, diagnosis, and care in the healthcare sector. This technology provides health companies with accessible solutions for managing life-threatening autoimmune disorders, aggressive cancers, addiction, and pain management.
Funding
Funding not disclosed
Founders
Product
Problem
Healthcare companies face challenges in effectively managing life-threatening autoimmune disorders, aggressive cancers, addiction, and pain management due to limitations in current diagnostic and treatment monitoring technologies. Existing methods may lack the accessibility and integration needed for comprehensive patient care.
Solution
AiTA develops a biology platform that leverages integrated micro-electro-mechanical systems (MEMS) to improve treatment, diagnosis, and overall care in the healthcare sector. This platform aims to provide health companies with accessible and integrated solutions for managing complex conditions. By utilizing MEMS technology, AiTA seeks to enhance the precision and efficiency of diagnostic and therapeutic processes. The platform's integrated approach allows for a more streamlined and comprehensive approach to patient care, potentially leading to better outcomes.
Target Audience
The primary target audience includes healthcare companies focused on managing autoimmune disorders, cancers, addiction, and pain management.
Features
- Integrated micro-electro-mechanical systems (MEMS) for enhanced biological analysis.